Tag: engineering
-
Brain-Computer Device Company Gains $33M in Early Funds
A company creating brain-computer interface devices to help people with disabling communications impairments is raising $33 million in its first venture round.
-
Measles-Rubella Patch Vaccine Shown Effective as Injection
A clinical trial shows a peel-and-stick patch device is as effective as a standard syringe injection in delivering a vaccine that protects against measles and rubella.
-
Biotech, Janssen Partner on Ultrasound for Gene Therapy
A developer of ultrasound bubbles to assist gene therapies is studying use of the technology with Janssen Pharmaceuticals for delivering DNA and RNA treatments.
-
Rare Disease Search Adds Large Language Model A.I.
A company offering a search engine to help diagnose rare diseases is integrating generative models from Open AI into its artificial intelligence algorithms.
-
Infographic – Climate Start-Ups Still Gaining Venture Funds
Despite a sharp downturn in venture dollars from 2021, new climate and weather forecasting companies continue to attract investments at historically high rates.
-
Collaboration to Boost Rare Disease Clinical Trials
An organization seeking new uses for today’s drugs and a contract research company aim to increase the number of clinical trials for rare diseases testing already approved drugs.
-
Quantum Technology Start-Up Accelerator Unveiled
A business incubator is underway to help start-up enterprises in Denmark working in quantum technologies, particularly with defense-related applications.
-
$15M Alternative Chicken, Fish Challenge Finalists Named
An international challenge competition seeking sustainable but realistic alternatives to natural chicken and fish protein named its six finalist teams.
-
Digital Diabetes System Shown to Cut Health Care Use
A study of people with type 2 diabetes shows those using a digital diabetes management system made fewer hospital visits than non-users over a 12-month period.
-
Computational Drug Discovery Company Acquires A.I. Businesses
Two companies using artificial intelligence to advance biotechnology and design new therapies are merging with a computational-engineering drug discovery enterprise.